Cutter & CO Brokerage, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutter & CO Brokerage, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$575,108
+2.7%
37,176
+4.3%
0.17%
+1.8%
Q2 2023$559,913
-1.9%
35,641
+2.9%
0.16%
-7.3%
Q1 2023$570,811
+6.5%
34,637
+0.8%
0.18%
-1.7%
Q4 2022$535,945
+11.0%
34,355
-7.8%
0.18%
+0.6%
Q3 2022$483,000
-17.9%
37,275
-10.9%
0.18%
-10.4%
Q2 2022$588,000
+11.2%
41,856
+13.2%
0.20%
+28.0%
Q1 2022$529,000
+14.8%
36,966
+9.2%
0.16%
+24.6%
Q4 2021$461,000
-0.6%
33,851
+19.6%
0.13%
+13.5%
Q3 2021$464,00028,3000.11%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders